osimertinib
astrazeneca
['start,(-starti),(-starte)', 'osimertinib']
#esmo22 osimertinib is well tolerated. but the threshold for toxicity can be different in someone who is already possibly cured and in someone asymptomatic at the start of therapy. only 2/3 in the osimertinib arm completed all three years. 
Director of Thoracic Oncology & Developmental Therapeutics @LombardiCancer, Associate Professor @Georgetown University #LCSM #HereWeGo #ITYSL He/Him